Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies

S. Karovic, Y. Wen, T. G. Karrison, G. L. Bakris, M. R. Levine, L. K. House, K. Wu, V. Thomeas, M. A. Rudek, J. J. Wright, E. E.W. Cohen, G. F. Fleming, M. J. Ratain, M. L. Maitland

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences